| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11K | +22.2% |
| Cost of Revenue | $4K | +22.2% |
| Gross Profit | $7K | +22.2% |
| R&D Expense | $2.4M | +21.8% |
| SG&A Expense | $3.2M | -9.0% |
| Operating Income | -$5.7M | -2.2% |
| Pre-tax Income | -$5.5M | -3.9% |
| Income Tax | $0 | — |
| Net Income | -$5.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Inventory | $2K | -66.7% |
| Current Assets | $6.1M | -40.3% |
| Total Assets | $6.7M | -37.8% |
| Current Liabilities | $328K | -11.8% |
| Total Liabilities | $328K | -11.8% |
| Stockholders' Equity | $6.3M | -38.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.3M | +34.0% |
| Investing Cash Flow | $6.3M | +83.4% |
| Financing Cash Flow | $1.5M | +636.9% |
| -3.9% |
| EPS (Diluted) | -$3.71 | +1.3% |